Healthtech funding in Q3 2022
European Healthtech startup funding raised during Q3 2022.
In Q3 2022, 142 European Healthtech companies closed 145 funding rounds and raised €1.8B in equity funding (excluding debt and grants), down 37.9% versus Q3 2021. Debt rounds added €381M. UK led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.8B
-37.9% vs Q3 2021 · excl. debt & grants · +€381M debt
Funding rounds
145
-24.5% vs Q3 2021
Companies
142
Top country
UK
Rank among sectors
#3
9.1% of sector funding
Debt financing
€381M
17.7% of total
Top-10 round share
54.2%
of disclosed capital
Rounds ≥ €100M
5
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q3 2022 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €927M | 52 |
| Aug | €701M | 42 |
| Sep | €523M | 51 |
Top countries
by € raisedHealthtech — top countries by capital, Q3 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, Q3 2022 | |
|---|---|
| UK | €705M |
| Germany | €338M |
| Switzerland | €323M |
| Sweden | €235M |
| France | €143M |
| Belgium | €120M |
| Iceland | €99M |
| Spain | €47M |
Stage mix
by € raisedHealthtech — stage mix, Q3 2022 — interactive chart.
Data table
| Healthtech — stage mix, Q3 2022 | |
|---|---|
| Other | €872M |
| Debt | €381M |
| Series A | €292M |
| Series B | €280M |
| Seed | €155M |
| Series D+ | €133M |
| Growth/Late | €16M |
| Grant | €13M |
| Pre-Seed | €3.6M |
| Early VC | €2.5M |
| Series C | €2.2M |
Top deals
largest disclosed rounds in Q3 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| CompuGroup Medical | Debt | Jul 2022 | €200M |
| Cera | Other | Aug 2022 | €157M |
| Cera | Debt | Aug 2022 | €157M |
| Kry | Other | Jul 2022 | €157M |
| Novaremed | Other | Jul 2022 | €127M |
| Kerecis | Series D+ | Jul 2022 | €99M |
| Sparingvision | Series B | Sep 2022 | €75M |
| Pheon Therapeutics | Series A | Sep 2022 | €71M |
| F2G | Other | Aug 2022 | €69M |
| Replay | Seed | Jul 2022 | €54M |
| Vectivbio | Other | Jul 2022 | €52M |
| Agomab Therapeutics | Series B | Jul 2022 | €41M |
| eTheRNA | Series B | Aug 2022 | €39M |
| Sanity Group | Series B | Sep 2022 | €39M |
| Ottonova | Other | Sep 2022 | €34M |
Top investors
most active in Q3 2022, by deal count- Bpifrance6 deals
- Calm Storm Ventures3 deals
- EIC Accelerator3 deals
- Fongit Innovation Fund (FIF)3 deals
- Forbion3 deals
- Speedinvest3 deals
- Venture Kick3 deals
- Verve Ventures3 deals
- Advent Life Sciences2 deals
- AlbionVC2 deals